| Customization: | Available |
|---|---|
| CAS No.: | 107452-89-1 |
| Environmental Protection: | Yes |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name: Ziconotide Cas No.: 107452-89-1 Purity: 99.0%min. Appearance: white powder Appearance: White Crystalline Lyophilized Powder Package: 1mg,2mg,5mg.10mg Shelf Life :24Months Storage:Refrigeration keep dry and away from light. Introduction: Ziconotide is the first of a new class of neurotherapy agents called N-type calcium channel blockers (NCCB).It can selectively act on n-type electrosensitive calcium channels in dendrite and axon terminal branches to inhibit the initial injurious stimulus afferent.Suitable for patients with severe chronic pain who require intrathecal treatment and are intolerant or ineffective to other analgesic treatments such as systemic analgesics or intrathecal.Intrasheathal injection of zekonopeptide can treat postherpetic neuralgia, phantom limb pain, HIV-related neuropathic pain, refractory cancer pain, and post-operative pain. |
| Product name: Ziconotide Cas No.: 107452-89-1 Purity: 99.0%min. Appearance: white powder Appearance: White Crystalline Lyophilized Powder Package: 1mg,2mg,5mg.10mg Shelf Life :24Months Storage:Refrigeration keep dry and away from light. Introduction: Ziconotide is the first of a new class of neurotherapy agents called N-type calcium channel blockers (NCCB).It can selectively act on n-type electrosensitive calcium channels in dendrite and axon terminal branches to inhibit the initial injurious stimulus afferent.Suitable for patients with severe chronic pain who require intrathecal treatment and are intolerant or ineffective to other analgesic treatments such as systemic analgesics or intrathecal.Intrasheathal injection of zekonopeptide can treat postherpetic neuralgia, phantom limb pain, HIV-related neuropathic pain, refractory cancer pain, and post-operative pain. |
){kind=link}